Targeting the chemotactic function of CD147 reduces collagen-induced arthritis.
CD147 is a type I transmembrane glycoprotein expressed on a wide variety of cell types, including all leucocytes. While CD147 is best known as a potent inducer of matrix metalloproteinases, it can also function as a regulator of leucocyte migration through its cell surface interaction with chemotactic extracellular cyclophilins. A potential role for CD147-cyclophilin interactions during inflammatory diseases, including rheumatoid arthritis (RA), is suggested from several studies. For example, CD147 expression is increased on reactive leucocytes in the synovial fluid and tissues of patients with arthritis. In addition, the synovial fluid of patients with RA contains high levels of extracellular cyclophilin A. In the current studies we investigated the contribution of the chemotactic function of CD147-cyclophilin interactions to joint inflammation using the mouse model of collagen-induced arthritis. Our data demonstrate that proinflammatory leucocytes, specifically neutrophils, monocytes and activated CD4(+) T cells, lose their ability to migrate in response to cyclophilin A in vitro when treated with anti-CD147 monoclonal antibody. Furthermore, in vivo treatment with anti-CD147 monoclonal antibody can reduce the development of collagen-induced arthritis in mice by >75%. Such findings suggest that CD147-cyclophilin interactions might contribute to the pathogenesis of RA by promoting the recruitment of leucocytes into joint tissues.
Damsker
Jesse M
JM
Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC 20037, USA.
Okwumabua
Ifeanyi
I
Pushkarsky
Tatiana
T
Arora
Kamalpreet
K
Bukrinsky
Michael I
MI
Constant
Stephanie L
SL
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D001169:Arthritis, Experimental / Q000276:immunology / Q000517:prevention & control*; D051926:Basigin / Q000276:immunology* / Q000378:metabolism; D002478:Cells, Cultured; D002630:Chemotactic Factors / Q000276:immunology*; D002634:Chemotaxis, Leukocyte / Q000276:immunology*; D018920:Coculture Techniques; D021984:Cyclophilin A / Q000378:metabolism; D004195:Disease Models, Animal; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D051379:Mice; D008811:Mice, Inbred DBA; D012720:Severity of Illness Index
D000911:Antibodies, Monoclonal; D002630:Chemotactic Factors; D051926:Basigin; D020780:Matrix Metalloproteinase 9; D021984:Cyclophilin A